NCT03160885 · Interventional trial
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Paddington Testing Company, Inc. · Philadelphia, PA · Philadelphia County
- Psoriasis Treatment Center of Central New Jersey · East Windsor, NJ · Mercer County
- Yardley Dermatology Associates · Yardley, PA · Bucks County
First posted
Registry updated
Added to the directory